📄Overview
All has invited open tender bids for "INSULIN DEGLUDAC(r-DNA ORIGIN) 100 IU/ML(EQ. 3.66 MG) 3 ML FLEXPEN/ IN PFS/ PRE FILL PEN INJECTION. QUOTE ITS BRAND NAME FORMULATION LIFE PRODUCT IMAGE ." at India — a Railway / Metro goods on a Goods basis, carrying an estimated value of an estimated under ₹1 Cr (derived from the EMD, as the department didn't publish a value). Bids close on 13 July 2026. EMD is ₹63 K. Reference 11265158.
🗓️Timeline
Published
—
Submission opens
—
Submission closes
13 Jul 2026
Bid opening
—
📎Tender documents
Documents are mirrored from the source portal for reference. Live bidding and authoritative documents remain on the official portal.
📋Complete tender details
🏷️ Identification
Tender IDIREPS-11265158
Reference No.11265158
OrganisationAll
Product categoryGoods & Services
💰 Commercials
Estimated valueunder ₹1 Cr (est)
Form of contractGoods
EMD₹62,670
Tender feeNil
⚖️ Process & eligibility
Tender typeOpen Tender
CategoryGoods
Two-stage bidding—
Withdrawal allowed—
📍 Location & authority
LocationIndia
Inviting authorityAll
❓Frequently asked questions
What is this tender for?
All floated this tender for "INSULIN DEGLUDAC(r-DNA ORIGIN) 100 IU/ML(EQ. 3.66 MG) 3 ML FLEXPEN/ IN PFS/ PRE FILL PEN INJECTION. QUOTE ITS BRAND NAME FORMULATION LIFE PRODUCT IMAGE ." — Railway / Metro work, procured as a goods contract on a Goods basis.
What is the estimated value?
The value wasn't published; based on the EMD it works out to about under ₹1 Cr.
What are the EMD and tender fee?
EMD is ₹63 K; tender fee is nil.
When do bids close?
Bids close on 13 July 2026.